OBJECTIVE: To evaluate the inter-relationships of age-and menopause-related changes of general obesity and body fat distribution and their independent effects on cardiovascular risk factors. DESIGN: Cross-sectional study. SUBJECTS: One-hundred and thirty-six premenopausal and 193 postmenopausal Chinese women with body mass index (BMI)`30 kgam 2 . MEASUREMENTS: Anthropometric surrogates of general obesity (BMI, total body fat percentage) and central obesity (waist-to-hip ratio, centrality index) were measured. Blood pressure, 75 g oral glucose tolerance test, glycosylated hemoglobin A 1c and lipid pro®les were also measured. RESULTS: Signi®cant correlation coef®cients between age, general obesity, central obesity and cardiovascular disease risk factors were noted. Through the menopausal transition, the BMI and total body fat percentage were increased signi®cantly. After adjustments for age and BMI, the postmenopausal women showed higher android fat percentage, centrality index, glycosylated hemoglobin A 1c , serum concentrations of total cholesterol, low-density lipoprotein (LDL) cholesterol and atherogenic indices than the premenopausal women. In multiple stepwise regression models, age exerted independent effects on oral glucose tolerance test 2 h plasma glucose level, systolic and diastolic blood pressure, total cholesterol level, and LDL cholesterol. Menopause was an independent variable in relation to the changes of glycosylated hemoglobin A 1c , total and LDL cholesterol levels, triglyceride levels and atherogenic indices. The centrality index was the major independent variable of all the cardiovascular disease risk factors, except total and LDL cholesterol level. However, the variation of total body fat percentage had no independent effect on any cardiovascular disease risk factors. CONCLUSION: Through the aging and menopausal effects, women will increase total body fat content, favoring the central body fat distribution. Age, menopause and central obesity were all independent and signi®cant factors to the cardiovascular disease risk factors in Chinese women.
Introduction
Through the effect of menopausal transition, the morbidity and mortality of cardiovascular diseases in women are increased. 1 When compared with premenopausal women, elevated blood pressure, increased glucose intolerance and dyslipidemia are not uncommon in postmenopausal women. Lack of the protection of estrogen has been supposed to be the major reason. 2, 3 However, several physiological changes which develop during menopause may also in¯uence the risk of cardiovascular disease, such as aging effect, 4 increased body weight or android pattern of body fat distribution, 5 decreasing resting metabolic rate and physical activity 5, 6 etc. Among these factors, the android pattern of body fat distribution seems to be the major issue. As we know, the android body fat distribution, glucose intolerance, hyperlipidemia, and hypertension appear to be clustered together in the same subject. 7, 8 In addition, gender differences in cardiovascular disease can be explained by the different patterning of body fat distribution, 9, 10 so it is reasonable to hypothesize that the menopause-related changes in cardiovascular disease risk factors might be partly due to the changes of patterning of body fat distribution.
According to a recent review, 11 the interrelationships between age, menopause, body fat distribution and cardiovascular risk factors are rather controversial. The ®rst argument is whether the menopause-related changes in body fat distribution are independent of age and general obesity. Most of the studies using indirect anthropometric methods (waist-to-hip ratio, waist circumference) have failed to con®rm the menopause-related effect on central obesity that was independent of age and body mass index, 12, 13 whereas others found supportive results.
14 The more precise methods (dual-energy X-ray absorptiometry (DEXA) or computed tomography) provided contrasting reports on the level of central obesity which would be increased during menopause, 15 ± 18 whereas other investigators have suggested that these changes are more dependent on age. 19 Recently, the method of ROIs (regions of interest) of DEXA has been proved a useful method in discriminating the differences in central obesity of glucose tolerance status in the Chinese population. 20 The ®rst objective of this study was therefore to clarify the complicated interrelationships of age, menopause, general obesity and body fat distribution measured by the ROIs of DEXA.
The second question is whether the menopauserelated changes of body fat distribution are associated with worsening cardiovascular disease risk factors. Although many reports have con®rmed the increase of cardiovascular diseases during menopause, 1 ± 3 only a few have mentioned the effect of menopause-related central obesity on the worsening cardiovascular disease risk factors. 18, 21, 22 However, some shortcomings associated with these studies include too few study subjects 18 and the use of relatively imprecise anthropometric methods (such as skinfold thickness and bioelectrical impedance analysis measurement). 21 Furthermore, most of the reports were predominantly done in Caucasian women where BMI, body fat distribution and its metabolic signi®cance may be quite different to those in the Chinese population. Given these facts, our second objective was to evaluate the independent effects of age, menopause, general obesity and body fat distribution on the cardiovascular risk factors in a relatively large group of Chinese women.
Methods

Subjects
A total of 512 Chinese women who received a 2 day hospitalized health examination at the National Cheng Kung University Hospital were enrolled. The exclusion criteria were peri-menopausal women, smokers, severe scoliosis, polio, cerebrovascular accidentrelated contractions, abnormal thyroid, renal or hepatic function, any malignancies (seven cases) and hysterectomized or ovariectomized women. None of the subjects were taking any medication known to signi®cantly affect body fat metabolism, such as hormone replacement therapy (17 
Anthropometric measurements
The body weight (to the nearest 0.1 kg) and body height (to the nearest 0.1 cm) of each subject were measured. Body mass index (BMI, kgam 2 ) was calculated accordingly. The waist-to-hip ratio (WHR) was de®ned as the ratio of waist circumference (measured at the level midway between the lateral lower rib margin and the superior anterior iliac crest) divided by hip circumference (measured at the level of the bilateral great trochanters). 26 The whole body composition was obtained directly by the method of dual energy X-ray absorptiometry (DEXA, Lunar radiation Corp, USA, software version 1.3 z). Total body fat percentage was de®ned as a ratio of total body fat massatotal tissue mass. 27 Four regions of interest (ROIs), android waist, android subscapular, gynoid hip and gynoid thigh, were de®ned accordingly. 20, 27 The centrality index was de®ned as the summation of fat mass in the two android ROIsathe summation of fat mass in the two gynoid ROIs ratio. 20, 27, 28 The proportion of fat (or lean) in android and gynoid ROIs was determined by the amount of fat (or lean) (expressed as a percentage of total body fat). In this study, the BMI and total body fat percentage re¯ected general obesity. The centrality index and WHR were used as the surrogate of central obesity.
Cardiovascular disease risk factors
After 10 h fasting, venous blood was sampled from each subject. The serum concentrations of the total cholesterol, triglyceride and high density lipoprotein cholesterol (HDL cholesterol) were measured. Low density lipoprotein cholesterol (LDL cholesterol) was calculated using the Freidewald formula. Atherogenic indices were calculated equal to the total cholesterolaHDL cholesterol ratio or the LDL cholesterolaHDL cholesterol ratio. 10 Each subject was instructed to have a daily intake of 150 g of carbohydrate for 3 days before examination. All subjects, with a normal diet for 3 days, subsequently received a 75 g oral glucose tolerance test. Fasting and 2 h plasma glucose concentrations were measured by the oxidation method. Glycosylated hemoglobin (HbA 1c , normal range 4.1 ± 6.0%) was measured by automatic high-performance liquid chromatography (Bio-Rad, Richmond, CA). Blood pressure was measured using a DINAMAP 2 vital sign monitor (Model 1846SX, Critikon Inc., USA) as recommended by the American Heart Association. 29 The weighted average measurement was adopted in this study. 
Results
Results of simple correlation coef®cients between age, general obesity, central fatness and cardiovascular disease risk factors in 329 women are shown in Table 1 . Age had signi®cant correlation coef®cients with general obesity (re¯ected by BMI and total body fat percentage), central obesity (re¯ected by WHR and centrality index) and all the cardiovascular disease risk factors, except the HDL cholesterol concentration. High correlation coef®cients were also found between BMI and total body fat percentage (0.811), and between WHR and centrality index (0.819).
Comparing with general obesity, central obesity showed higher correlation coef®cients with age and all of the cardiovascular disease risk factors. Table 2 shows the menopausal effect on general obesity and central obesity. The BMI and total body fat percentage were increased signi®cantly in postmenopausal women. After adjustment for BMI, the postmenopausal women had higher android ROIs fat, lower gynoid ROIs fat and more central obesity as re¯ected by higher WHR and centrality index than the premenopausal women. Meanwhile, a signi®cant decrease of gynoid ROIs lean tissue mass was found during menopause. When further adjusted for age, only the differences of android ROIs fat and centrality index still existed between pre-and post-menopausal women. The menopause-associated changes in the cardiovascular disease risk factors are shown in Table 3 . After adjustments for age and BMI, the postmenopausal women had higher glycosylated hemoglobin A 1c , serum concentrations of total cholesterol and LDL cholesterol, and atherogenic indices than the pre-menopausal women.
The colinearity between independent variables was evaluated by the level of tolerance. For the total subjects, the level of tolerance between independent variables were as follows: age 0.186; menopause 0.210; BMI 0.278; WHR 0.228; total body fat percentage 0.334; centrality index 0.318. As a Log-transformed before statistical analysis. Age, menopause, central obesity and atherosclerosis C-J Chang et al low colinearity was found between independent variables, the age, menopausal status, total body fat percentage and centrality index were considered to be independent variables within multiple stepwise regression model analysis for each cardiovascular disease risk factor. Table 4 shows the multiple stepwise regression model of each cardiovascular disease risk factor and R 2 value of each model. Age was an independent factor on oral glucose tolerance test (OGTT) 2 h plasma glucose, systolic and diastolic blood pressure, serum concentration of total cholesterol and LDL cholesterol. Menopause-related independent effects were found in glycosylated hemoglobin A 1c , serum concentration of total and LDL cholesterol, triglyceride level and atherogenic indices. The centrality index showed a signi®cant independent effect on all the cardiovascular disease risk factors, except for the serum concentration of total and LDL cholesterol. However, no independent effect of total body fat percentage on cardiovascular disease risk factors could be found in any of the models.
Discussion
Are the changes of body fat distribution during menopause predominantly age-or menopauserelated? Consistent with other reports, 5,14 ± 17 menopause-related increasing total body fat with central obesity was ascertained in this study. Several studies have also proved that hormone replacement therapy can prevent the increment of total body fat and abdominal fat that occurs after estrogen depletion during menopause. 24, 30 These results seemed to support the unique and important effect of menopause on changes in body composition. 6 On the other hand, through the aging process, the fat-free mass will be decreased and the body composition will encompass more fat tissue mass with the tendency of central accumulation. 4 Meanwhile, the high correlation coef®cients between age and anthropometric variables in our study suggested that the in¯uence of age on the changes of body fat distribution was also important. 19 Collectively speaking, the increments of total body fat and central fat distribution during menopausal traverse were in¯uenced independently by both menopausal and aging changes in Chinese women.
The menopausal differences of cardiovascular disease risk factors in our study were also compatible with previous published reports. 18, 21, 22 Several variables, including age, menopause, general obesity and body fat distribution, had all been used to explain these menopausal differences. 18, 21, 31 In our regression models, although age and menopause had shown independent effects on the part of the cardiovascular disease risk factors, the effects of central adiposity mediated most of the changes of cardiovascular disease risk factors. As age and menopause can both in¯uence the changes in body fat distribution, it could be hypothesized that central obesity resulted from the menopausal effect before affecting the cardiovascular Age, menopause, central obesity and atherosclerosis C-J Chang et al disease risk factors. 18 On the other hand, intra-abdominal fat and trunk fat may also put women at increased risk of developing cardiovascular disease directly. 22 Moreover, we con®rmed that central obesity was the major independent factor associated with worsened cardiovascular disease risk factors after menopause. 31 The controversial reports of menopausal-related changes in body fat distribution and effects on cardiovascular disease risk factors may be due to several reasons. Firstly, the discrepancies among the results may partly be due to a lack of standard methods of anthropometric measurement. As the changes in body fat distribution during menopause were gradual and subtle, the relatively imprecise anthropometric methods (such as body circumferences and WHR) always failed to detect such changes. 11 ± 13 In this study, after adjustments were made for age and BMI, the differences of the waist circumference and WHR were nonsigni®cant. However, the differences of android ROIs, fat and centrality index derived from the method of ROIs of DEXA were still signi®cant. This means that the ROIs of DEXA were more precise in evaluating the central obesity than WHR 20 and DEXA was a better method in detecting the menopause-related changes in body fat distribution. 15 ± 18 Secondly, confounding factors may possibly interfere in the analysis of menopausal-related changes in body fat distribution and cardiovascular disease risk factors. There are different fat distribution and glucose metabolism mechanisms between obese and nonobese women. 32, 33 The subjects analyzed in the previous studies may have also been too few to ®nd the actual differences between pre-and post-menopausal women. Hence, it is not surprising to ®nd discrepancies in the results owing to these confounding factors in the previous reports. 19 Finally, inappropriate statistical methods may lead to misinterpretation of the actual effects of age, menopause and body fat distribution on cardiovascular disease risk factors. During the course of menopause, the changes in fat distribution and related cardiovascular disease risk factors were always gradual and subtle. However, unsuitable adjustment as a whole may bias the results from the small but signi®cant difference toward uni®ed results. 11, 34 For this reason, although the menopausal differences of central obesity and cardiovascular disease risk factors still existed after adjustments for age and BMI, we further used the method of standardized regression coef®-cients to analyze the independent effects of age, menopause, general obesity and central obesity on each cardiovascular disease risk factor accordingly. Our results con®rmed that age, menopause and central obesity had signi®cant independent effects on cardiovascular disease risk factors in Chinese women.
The mechanism of the menopause-related changes of body fat distribution has been extensively studied. 6, 35 Under the effect of estrogenic depletion after menopause, the postmenopausal women had lower sex hormone binding globulin, relatively higher androgenicity and higher activity of lipoprotein lipase in the abdominal subcutaneous adipose tissue than the premenopausal women. 8, 13, 36, 37 These physiological changes may result in a more male, central adipose tissue distribution after menopause. 11 Meanwhile, the fact that hormone replacement therapy can prevent central distribution of body fat indicates the important role of the sex hormone. 24, 30 Furthermore, normal menopause is associated with reduced energy expenditure (REE). 5 The variation of REE was further signi®cantly associated with the difference of trunk lean and fat tissue mass. 38 In contrast, it has been demonstrated that increasing physical activity may decrease the amount of intra-abdominal fat and further mitigate the risk of cardiovascular diseases in pre-and post-menopausal women. 31 So, relative physical inactivity 39 and decreased energy expenditure after menopause may deteriorate the central body fat distribution. 5, 6 Finally, genetic factors may explain the 60 ± 70% variance of total and central body fat in women after menopause. 25, 40 These results suggest the existence of genes speci®c for central adiposity in women.
In conclusion, both the menopausal and aging effects independently in¯uence the increments of general obesity and the tendency of central body fat accumulation in women after menopause. The centrality index derived from the method of ROIs of DEXA is a useful method in evaluating the menopause-related changes of central obesity. In comparison with the premenopausal women, the postmenopausal women had worsened cardiovascular disease risk factors, which were mediated by the independent effects of age, menopause and especially central fat distribution.
